Regeneron Pharmaceuticals Inc (REGN)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 29,353,600 | 25,973,100 | 22,664,000 | 18,768,800 | 11,025,300 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $29,353,600K)
= 0.00
The debt-to-capital ratio of Regeneron Pharmaceuticals Inc has shown a consistent downward trend over the past five years, decreasing from 0.15 as of December 31, 2020, to 0.06 as of December 31, 2024. This indicates that the company has been effectively reducing its reliance on debt in relation to its total capital structure. A lower debt-to-capital ratio suggests a healthier financial position and lower financial risk, as the company is using less debt to finance its operations compared to its equity. Overall, this trend reflects positively on the company's financial strength and stability.
Peer comparison
Dec 31, 2024